Literature DB >> 11023551

ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.

T A Thompson1, J D Haag, M N Gould.   

Abstract

Carcinoma induction in the rat mammary carcinogenesis model is age dependent. In this study, mammary cancer susceptibility and ras gene activation were investigated in rats exposed to N:-methyl-N:-nitrosourea (NMU) at 2, 6, 8 and 15 months. Animals were resistant to NMU-induced mammary tumor development when exposed at 6 and 8 months of age, whereas a significant number of mammary carcinomas developed in animals exposed to NMU at 2 and 15 months of age. G35-->A35 activating mutations in the Harvey ras gene were found only in mammary carcinomas from rats exposed to NMU at 2 months of age, but not in tumors that developed in animals exposed to NMU at 15 months of age. No G35-->A35 activating mutations were present in the Kirsten ras gene of any of the mammary tumors. Additional analysis of exons 1 and 2 of the Harvey ras gene from mammary carcinomas that developed in animals exposed to NMU at 15 months of age did not reveal any other activating mutations in this gene. In mammary carcinomas from animals exposed to NMU at 2 months of age, the frequency of mammary carcinomas with mutations in the Harvey ras gene was independent of the time from which the tumor first appeared. Therefore, age at the time of carcinogen exposure plays a critical role in both breast cancer susceptibility and the molecular events that contribute to mammary carcinoma development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023551     DOI: 10.1093/carcin/21.10.1917

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection.

Authors:  Shuo Li; Shelley A Gestl; Edward J Gunther
Journal:  Cancer Prev Res (Phila)       Date:  2019-11-07

2.  Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma.

Authors:  Maricel V Maffini; Janine M Calabro; Ana M Soto; Carlos Sonnenschein
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo.

Authors:  D M Vigushin; N Mirsaidi; G Brooke; C Sun; P Pace; L Inman; C J Moody; R C Coombes
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

4.  Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo.

Authors:  María L Lavaggi; Mauricio Cabrera; Cristina Pintos; Carolina Arredondo; Gisela Pachón; Jorge Rodríguez; Stella Raymondo; José Pedro Pacheco; Marta Cascante; Claudio Olea-Azar; Adela López de Ceráin; Antonio Monge; Hugo Cerecetto; Mercedes González
Journal:  ISRN Pharmacol       Date:  2011-06-22

5.  Karyotypic evolutions of cancer species in rats during the long latent periods after injection of nitrosourea.

Authors:  Mathew Bloomfield; Amanda McCormack; Daniele Mandrioli; Christian Fiala; C Marcelo Aldaz; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2014-12-16       Impact factor: 2.009

6.  Vitamin D3 constrains estrogen's effects and influences mammary epithelial organization in 3D cultures.

Authors:  Nafis Hasan; Carlos Sonnenschein; Ana M Soto
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.